Tölg et al., 1997 - Google Patents
Influence of alpha-and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat heartsTölg et al., 1997
- Document ID
- 1521003837475979748
- Author
- Tölg R
- Kurz T
- Ungerer M
- Schreieck J
- Görge B
- Richardt G
- Publication year
- Publication venue
- Naunyn-Schmiedeberg's archives of pharmacology
External Links
Snippet
Although it is generally accepted that adrenergic influences contribute to arrhythmias during myocardial ischemia, it is still a matter of debate whether these arrhythmogenic effects are mediated via alpha-or beta-adrenergic receptors and which particular receptor subtype is …
- 208000003663 Ventricular Fibrillation 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propanolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N-O-); Hydrazines (>N-N<); Hydrazones (>N-N=) Imines (C-N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moravec et al. | Inotropic effects of angiotensin II on human cardiac muscle in vitro. | |
| Starke et al. | Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional α-receptors | |
| Thandroyen et al. | Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart. | |
| Yasutake et al. | Exacerbation of reperfusion arrhythmias by α1 adrenergic stimulation: a potential role for receptor mediated activation of sarcolemmal sodium-hydrogen exchange | |
| Chahine et al. | Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. | |
| Tölg et al. | Influence of alpha-and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts | |
| Lubbe et al. | Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart | |
| Corr et al. | Enhanced alpha-adrenergic responsiveness in ischemic myocardium: role of alpha-adrenergic blockade | |
| KR19990023904A (en) | Sodium / Hydrogen Exchanger Inhibitors and Pharmaceutical Pharmaceutical Formulations for Cardiovascular Disease | |
| Schömig et al. | The role of catecholamines in ischemia | |
| D'Amico et al. | Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists | |
| Billman | The antiarrhythmic and antifibrillatory effects of calcium antagonists | |
| Draper et al. | Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart | |
| Dhalla et al. | Catecholamine-induced cardiomyopathy | |
| Davey | Alpha adrenoceptors—An overview | |
| Winslow et al. | Comparative effects of fast-and slow-ion channel blocking agents on reperfusion-induced arrhythmias in the isolated perfused rat heart | |
| Haynes et al. | α‐Adrenoceptor mediated responses of the cauda epididymis of the guinea‐pig | |
| Fukuchi et al. | Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil | |
| Chess-Williams et al. | Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial alpha-adrenoceptor responsiveness. | |
| Musters et al. | Norepinephrine pretreatment attenuates Ca2+ overloading in rat trabeculae during subsequent metabolic inhibition: Improved contractile recovery via an α1-adrenergic, PKC-dependent signaling mechanism | |
| Crockett et al. | Sarafotoxin 6c protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat | |
| Parratt et al. | Catecholamines and early post-infarction arrhythmias: the effects of α-and β-adrenoceptor blockade | |
| Tölg et al. | Ischemia-induced ventricular fibrillation in isolated perfused rat heart: role of alpha 1A-adrenoceptor mediated activation of protein kinase C | |
| Flores et al. | Cardiac electrophysiological effects of platelet-derived substances | |
| Szekeres et al. | Effect of adrenergic activators and inhibitors on the electrical activity of the heart |